Abramson Cancer Perelman Center for Advanced Medicine, University of Pennsylvania is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.
Abramson Cancer Perelman Center for Advanced Medicine, University of Pennsylvania has participated in 1 clinical trials.
Therapeutic areas: Acute Graft-Versus-Host Disease, GIGVHD.
Sponsors: Alexion Pharmaceuticals, Inc..
Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Abramson Cancer Perelman Center for Advanced Medicine, University of Pennsylvania has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Abramson Cancer Perelman Center for Advanced Medicine, University of Pennsylvania has 1 clinical trials on record. Their work covers Acute Graft-Versus-Host Disease, GIGVHD.
Abramson Cancer Perelman Center for Advanced Medicine, University of Pennsylvania has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.